Trial Profile
The Effect and Reliability of Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Anxiety disorders; Major depressive disorder
- Focus Therapeutic Use
- 25 Apr 2017 New trial record